Overview
Aytu is committed to improving patients’ health everywhere. Our prescription therapeutics help patients lead healthier and more fulfilling lives. Our product portfolio addresses ADHD (Attention Deficit-Hyperactivity Disorder), allergies and fluoride deficiency. Our patient-first team is proud to deliver these innovative treatments through a best-in-class patient support program called Aytu RxConnect.
Leadership
Decades of experience with a focus on better health today.
The Aytu leadership team is as unique as our portfolio of products. Our experience spans decades, but we never stop thinking about the future.
Management Team
Margaret Cabano
Vice President of Operations
Bio 
Jarrett Disbrow
Chief Business Officer
Bio
Josh Disbrow
Chief Executive Officer
Bio
Suzane Kennedy
Vice President of Regulatory Affairs and Quality Assurance
Bio
Greg Pyszczymuka
Chief Commercial Officer
Bio
Ryan Selhorn
Chief Financial Officer
Bio
Board of Directors
Josh Disbrow
Chief Executive Officer
Bio
John Donofrio, Jr.
Chairman, Audit Committee Chair
Bio
Carl Dockery
Director, Nominating & Governance Committee Chair
Bio
Abhinav “Abi” Jain
Independent Director
Bio
Vivian Liu
Director, Compensation Committee Chair
Bio
Our Mission & Vision
We aspire to be a leading specialty pharmaceutical company. We will achieve this by commercializing novel therapeutics, providing best-in-class patient access, unleashing the talents of our people, and developing important and needed therapeutics for patients.
- We will make a lasting difference in patient’s lives by delivering the best and most innovative products.
- Our individual actions, collective attitude, and company results will inspire others to do great things.
- Our people, products and platform will affect positive change in healthcare delivery and patient outcomes.
Environmental, Social, & Governance
At Aytu, we take pride in honoring our Mission and Vision to be an innovative force in pharmaceuticals. In doing so, we hold ourselves accountable to the highest standards of ethical principles to serve our stakeholders: our patients, employees, customers, shareholders, and communities alike. We focus our corporate sustainability efforts on addressing Environmental, Social, and Governance (ES&G) Issues.
Environmental, Social, and Governance efforts are at our core. Growth of our organization translates to progression of our ES&G strategy as we strive to exceed ES&G requirements and stakeholder expectations.
Environmental
At Aytu, we believe in preserving our planet’s natural resources while simultaneously minimizing our environmental impact. Reduction of energy use, waste, and pollution are at the core of our sustainability practices. Not only are these our corporate objectives, but we also believe that is the right and responsible thing to do.
Social
In our eyes, supporting our employees and the communities they serve is the lifeblood of a socially responsible organization. We have established multiple corporate partnerships within the communities we support by way of sponsorships, donations, fundraising efforts, and our direct efforts through volunteership. A positive corporate culture comprised of good corporate citizens is at the heart of our core values.
Governance
Inclusive, compliant, and ethical business practices are the foundation of our organization. We employ diverse hiring practices, adhere to the highest standards of quality, and focus on governmental compliance with all key industry regulators. We have a unified mission and expect a high level of performance and ethical behavior from our Board, corporate officers, employees, and business partners.
Corporate Governance, Board Composition & Diversity Matrix
Aytu is fully committed to adhering to the highest standards of ethical business practice. We have created a company structure that adheres to the highest standards of conduct. Our board, and every one of our employees and partners, is dedicated to doing business for the well-being of our customers. Further, our board is comprised of experienced, successful professionals who bring a range of diverse backgrounds to support the company’s strategies and growth plans. Through this diverse set of skills and backgrounds – and a distinct focus on serving patients – we are positioned to drive value for all stakeholders.
Board Demographics
Total Number of Directors | 5 | |||
Part I: Gender Identity | ||||
Male | Female | |||
Directors | 4 | 1 | ||
Part II: Demographic Background | ||||
White | 3 | 0 | ||
Asian | 1 | 1 | ||
As part of building a diverse leadership team, bringing in broad sets of skills and experiences is important to us. We value the complementary experiences our board members have and seek to integrate diverse functional area and strategic skills into our decision making that maximizes value for all stakeholders.
Director Experiences and Qualifications
Disbrow | Donofrio | Dockery | Jain | Liu | |
Public Company Board | ● | ● | |||
Public Company Executive | ● | ● | ● | ||
Pharmaceutical Industry | ● | ● | ● | ● | ● |
Clinical Development | ● | ||||
Finance & Accounting | ● | ● | ● | ● | |
Capital Markets | ● | ● | ● | ||
Commercial Operations | ● | ● | |||
Sales & Marketing | ● | ● | |||
Supply Chain/Logistics | ● | ● | |||
Strategic Planning | ● | ● | ● | ||
Mergers & Acquisitions/Corporate Development | ● | ● | ● | ● | |
Talent Acquisition | ● | ● | ● |
The links below spell out complete information for all Aytu corporate ethics and practices.
- Code of Business Conduct and Ethics
- Code of Ethics for Chief Executive Officer and Senior Financial Officers
- Audit Committee Charter
- California Comprehensive Compliance Program
- Compensation Committee Charter
- Nominating and Governance Committee Charter
- Audit Committee Complaint Procedures
- Statement of Insider Trading Policy
- Whistleblower Hotline
1-844-TELL-AYTU
(1-844-835-5298)
Aytu Hotline
Aytu Email Hotline
Business Development
Partnering for growth and improving patient health.
Aytu is constantly exploring alliances to strengthen our product portfolio. We’re actively seeking to license and/or acquire specialty products – with an emphasis on products that fulfill unmet needs and improve over existing therapies. We are also seeking partners outside the U.S. to commercialize our novel ADHD medicines. We are committed to improving patients’ health worldwide by forging strong partnerships. If you are interested in discussing product opportunities, please contact us today.